BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hooker SE Jr, Woods-Burnham L, Bathina M, Lloyd S, Gorjala P, Mitra R, Nonn L, Kimbro KS, Kittles RA. Genetic Ancestry Analysis Reveals Misclassification of Commonly Used Cancer Cell Lines. Cancer Epidemiol Biomarkers Prev 2019;28:1003-9. [PMID: 30787054 DOI: 10.1158/1055-9965.EPI-18-1132] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Breen N, Berrigan D, Jackson JS, Wong DWS, Wood FB, Denny JC, Zhang X, Bourne PE. Translational Health Disparities Research in a Data-Rich World. Health Equity 2019;3:588-600. [PMID: 31720554 DOI: 10.1089/heq.2019.0042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Makboul R, Abdelkawi IF, Badary DM, Hussein MRA, Rhim JS, Toraih EA, Zerfaoui M, Abd Elmageed ZY. Transmembrane and Tetratricopeptide Repeat Containing 4 Is a Novel Diagnostic Marker for Prostate Cancer with High Specificity and Sensitivity. Cells 2021;10:1029. [PMID: 33925440 DOI: 10.3390/cells10051029] [Reference Citation Analysis]
3 Mitra Ghosh T, White J, Davis J, Mazumder S, Kansom T, Skarupa E, Barnett GS, Piazza GA, Bird RC, Mitra AK, Yates C, Cummings BS, Arnold RD. Identification and Characterization of Key Differentially Expressed Genes Associated With Metronomic Dosing of Topotecan in Human Prostate Cancer. Front Pharmacol 2021;12:736951. [DOI: 10.3389/fphar.2021.736951] [Reference Citation Analysis]
4 Lowder D, Rizwan K, McColl C, Paparella A, Ittmann M, Mitsiades N, Kaochar S. Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics. Cancer Lett 2022:S0304-3835(22)00044-1. [PMID: 35122875 DOI: 10.1016/j.canlet.2022.01.028] [Reference Citation Analysis]
5 Gorjala P, Kittles RA, Goodman OB Jr, Mitra R. Role of CYP3A5 in Modulating Androgen Receptor Signaling and Its Relevance to African American Men with Prostate Cancer. Cancers (Basel) 2020;12:E989. [PMID: 32316460 DOI: 10.3390/cancers12040989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Raghavan S. How inclusive are cell lines in preclinical engineered cancer models? Dis Model Mech 2022;15:dmm049520. [PMID: 35642685 DOI: 10.1242/dmm.049520] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bisogno LS, Yang J, Bennett BD, Ward JM, Mackey LC, Annab LA, Bushel PR, Singhal S, Schurman SH, Byun JS, Nápoles AM, Pérez-Stable EJ, Fargo DC, Gardner K, Archer TK. Ancestry-dependent gene expression correlates with reprogramming to pluripotency and multiple dynamic biological processes. Sci Adv 2020;6:eabc3851. [PMID: 33219026 DOI: 10.1126/sciadv.abc3851] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Gaballa R, Ali HEA, Mahmoud MO, Rhim JS, Ali HI, Salem HF, Saleem M, Kandeil MA, Ambs S, Abd Elmageed ZY. Exosomes-Mediated Transfer of Itga2 Promotes Migration and Invasion of Prostate Cancer Cells by Inducing Epithelial-Mesenchymal Transition. Cancers (Basel) 2020;12:E2300. [PMID: 32824235 DOI: 10.3390/cancers12082300] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
9 Johnson JR, Woods-Burnham L, Hooker SE Jr, Batai K, Kittles RA. Genetic Contributions to Prostate Cancer Disparities in Men of West African Descent. Front Oncol 2021;11:770500. [PMID: 34820334 DOI: 10.3389/fonc.2021.770500] [Reference Citation Analysis]
10 Wright N, Gong Z, Kittles R, Natarajan R, Jovanovic-Talisman T, Rida P, LaBarge M, Seewaldt V. Kinesin Family Member C1 (KIFC1/HSET): A Potential Actionable Biomarker of Early Stage Breast Tumorigenesis and Progression of High-Risk Lesions. J Pers Med 2021;11:1361. [PMID: 34945833 DOI: 10.3390/jpm11121361] [Reference Citation Analysis]